Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma

Digestive Diseases and Sciences
R KimJ C Reynolds

Abstract

We sought to determine if an immunohistochemical panel of p53, PCNA, and c-erbB-2 was a useful biomarker of transformation in Barrett's metaplasia. P53, PCNA, and c-erbB-2 immunohistochemistry was performed on resected Barrett's specimens selected to show discrete grades of dysplasia and then on prospectively obtained biopsies. In resection specimens, p53 was positive in 36% with no dysplasia, in 30% with low-grade dysplasia, in 85% with high-grade dysplasia, and in 90% of adenocarcinomas. While an evaluation of proliferation throughout the specimen did not differ between groups, surface proliferation was significantly higher in high-grade dysplasia than in low-grade or no dysplasia. All high-grade dysplasia specimens were positive for at least one marker, compared to 44% with no or low-grade dysplasia. C-erbB-2 was only seen in 31% with high-grade dysplasia and in 10% of adenocarcinomas. Prospectively, the panel had a sensitivity of 100%, a specificity of 81% and an overall accuracy of 83% in identifying patients who developed high-grade dysplasia or cancer. Thus, overexpression of p53 occurs early in the malignant transformation of Barrett's and increases with histologic progression, and proliferation at the surface of Barret...Continue Reading

Citations

Jul 19, 2001·Cancer Investigation·J S Ross, B J McKenna
May 26, 2001·The American Journal of Gastroenterology·B J Reid
Jul 12, 2002·American Journal of Clinical Pathology·Helene GeddertMario Sarbia
Apr 22, 2003·International Journal of Cancer. Journal International Du Cancer·Hubert MörkJosef Köhrle
Mar 24, 2009·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M BinatoM I Edelweiss
Jul 30, 2009·The American Journal of Gastroenterology·Marjolein SikkemaErnst J Kuipers
Feb 14, 2015·Journal of Gastrointestinal Cancer·Hanne OomsTom G Moreels
Dec 5, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Uta ReicheltGuido Sauter
Sep 28, 2004·The American Journal of Gastroenterology·Hashem B El-SeragRichard E Sampliner
Apr 1, 2003·Expert Opinion on Investigational Drugs·M R Anderson, J A Z Jankowski
May 28, 2009·Journal of Cancer Research and Clinical Oncology·Pietro CrispinoPaolo Paoluzi
Sep 27, 2000·Baillière's Best Practice & Research. Clinical Gastroenterology·S J Spechler
Jul 24, 2002·Gastroenterology Clinics of North America·Marian M Haber
Jul 24, 2002·Gastroenterology Clinics of North America·James C ReynoldsDavid Hirschl
Jul 24, 2002·Gastroenterology Clinics of North America·Michelle Beilstein, Debra Silberg
Mar 1, 2000·Gastroenterology Clinics of North America·J C ReynoldsR R Yassin
Jan 24, 2007·Thoracic Surgery Clinics·Thomas A D'Amico

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.